Spots Global Cancer Trial Database for pheochromocytoma
Every month we try and update this database with for pheochromocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy | NCT06427798 | Somatostatin Re... Gastrointestina... Pheochromocytom... Paragangliomas | 68Ga-DOTATATE [203Pb]VMT-alph... [212Pb]VMT-alph... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| China Adrenal Disease Registry | NCT04890444 | Cushing Syndrom... Aldosteronism Hypoadrenalism Congenital Adre... Adrenal Adenoma Adrenal Inciden... Adrenal Carcino... Pheochromocytom... | 16 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | ||
| Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | NCT04891081 | Acyanotic Conge... Cyanotic Congen... Pheochromocytom... Paraganglioma | 18 Years - | University Medical Centre Ljubljana | ||
| Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma | NCT00911729 | Pheochromocytom... Paraganglioma | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | ||
| The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma | NCT05702944 | Pheochromocytom... Paraganglioma Adrenalectomy; ... Adrenergics Cau... | Phenoxybenzamin... | 19 Years - 70 Years | Seoul National University Hospital | |
| Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma | NCT06062082 | Pheochromocytom... Non-Secretory A... | adrenalectomy | 18 Years - 80 Years | Central Hospital, Nancy, France | |
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma | NCT04187404 | Adrenocortical ... Pheochromocytom... Paraganglioma | EO2401 Nivolumab | 18 Years - | Enterome | |
| Magnesium and Dexmedetomidine in Pheochromocytoma | NCT05102058 | Phaeochromocyto... Hemodynamic Ins... | Magnesium-Dexme... | 18 Years - 75 Years | Istanbul University | |
| Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors | NCT05636618 | Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Tumor... Carcinoid Tumor Paraganglioma Pheochromocytom... | [212Pb]VMT-α-NE... [212Pb]VMT-α-NE... | 18 Years - 90 Years | Perspective Therapeutics | |
| Expanded Access Protocol Using 131I-MIBG | NCT01590680 | Neuroblastoma Pheochromocytom... Paraganglioma | I-131 MIBG | 12 Months - | Jubilant DraxImage Inc. | |
| Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy | NCT01959711 | Adrenal Tumor Pheochromocytom... Conn's Syndrome Cushing's Syndr... | Posterior RA Lateral transpe... | 18 Years - 80 Years | Jagiellonian University | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders | NCT00001238 | Kidney Cancer Urologic Malign... Renal Cell Carc... Familial Renal ... Clear Cell Rena... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| "Receptor Radionuclide Therapy With 177Lu-DOTATOC | NCT06045260 | Neuroendocrine ... Paraganglioma Pheochromocytom... | 177Lu-DOTATOC | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| China Adrenal Disease Registry | NCT04890444 | Cushing Syndrom... Aldosteronism Hypoadrenalism Congenital Adre... Adrenal Adenoma Adrenal Inciden... Adrenal Carcino... Pheochromocytom... | 16 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | ||
| Expanded Access Protocol Using 131I-MIBG | NCT01590680 | Neuroblastoma Pheochromocytom... Paraganglioma | I-131 MIBG | 12 Months - | Jubilant DraxImage Inc. | |
| Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma | NCT01838187 | Neuroblastoma Pheochromocytom... Paraganglioma | I-131 MIBG Vorinostat | 12 Months - | Children's Hospital Medical Center, Cincinnati | |
| I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma | NCT00590096 | Neuroblastoma Pheochromocytom... | 2 Weeks - | Children's Hospital Medical Center, Cincinnati | ||
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma | NCT04187404 | Adrenocortical ... Pheochromocytom... Paraganglioma | EO2401 Nivolumab | 18 Years - | Enterome | |
| 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor | NCT05069220 | Neuroendocrine ... Neuroblastoma Pheochromocytom... Paraganglioma | 18F-MFBG 68Ga-Dotatate | 1 Year - 80 Years | Peking Union Medical College Hospital | |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. | NCT04276597 | Pulmonary Neuro... Pheochromocytom... Paraganglioma Thymus Carcinoi... Unknown Primary... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-DOTATOC | 18 Years - | Excel Diagnostics and Nuclear Oncology Center | |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | NCT01373736 | Pheochromocytom... Neuroblastoma Paraganglioma Medullary Thyro... Carcinoid Tumor... | 123I-meta-iodob... | - | Vancouver Coastal Health | |
| Surgeon-Anesthesiologist Collaboration | NCT03158870 | Pheochromocytom... Collaboration | Surgery complic... | 18 Years - | Hospices Civils de Lyon | |
| Pheochromocytoma and Hemodynamic Instability | NCT04566406 | Pheochromocytom... Hypertension Surgery | Laparoscopic ad... | 18 Years - | Jagiellonian University | |
| Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma | NCT00843037 | Paraganglioma Pheochromocytom... | Sunitinib | 18 Years - | University Health Network, Toronto | |
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma | NCT00107289 | Neuroblastoma Pheochromocytom... | iobenguane I 13... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | NCT04891081 | Acyanotic Conge... Cyanotic Congen... Pheochromocytom... Paraganglioma | 18 Years - | University Medical Centre Ljubljana | ||
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents | NCT03923257 | Neuroendocrine ... Pheochromocytom... Paraganglioma | 177Lu-DOTA-tyr3... Peptide Recepto... | 1 Year - 20 Years | University of Iowa | |
| Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | NCT04400474 | Neuroendocrine ... Anaplastic Thyr... Adenocarcinoma Pheochromocytom... Paraganglioma | Cabozantinib 40... | 18 Years - | Grupo Espanol de Tumores Neuroendocrinos | |
| Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy | NCT06427798 | Somatostatin Re... Gastrointestina... Pheochromocytom... Paragangliomas | 68Ga-DOTATATE [203Pb]VMT-alph... [212Pb]VMT-alph... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | NCT04119024 | Metastatic Mali... Metastatic Mela... Pathologic Stag... Pathologic Stag... Recurrent Malig... Refractory Mali... Uveal Melanoma Acral Melanoma Neuroendocrine ... Paraganglioma Pheochromocytom... Adrenocortical ... Pancreatic Neur... Thyroid Cancer Breast Cancer Lung Adenocarci... Head and Neck S... | Biopsy Biospecimen Col... Computed Tomogr... Cyclophosphamid... Fludarabine Pho... Fludeoxyglucose... IL13Ralpha2-spe... Magnetic Resona... Positron Emissi... | 18 Years - 70 Years | Jonsson Comprehensive Cancer Center | |
| First-line Anlotinib Combined With Penpulimab for Advanced Pheochromocytoma: A Single-arm, Multicenter, Prospective Phase II Study | NCT06429397 | Pheochromocytom... | Anlotinib and P... | 18 Years - 75 Years | Sun Yat-sen University | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma | NCT00126412 | Pheochromocytom... Neuroblastoma | 123I-mIBG (meta... | - | GE Healthcare | |
| Metanephrines in Obstructive Sleep Apnoea | NCT05053685 | Pheochromocytom... Obstructive Sle... Catecholamine; ... | Measurement of ... | 21 Years - 70 Years | Changi General Hospital | |
| Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card | NCT02672020 | Adrenal Gland N... | omics identity ... | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
| Phenoxybenzamine Versus Doxazosin in PCC Patients | NCT01379898 | Pheochromocytom... | Phenoxybenzamin... Doxazosin | 18 Years - | University Medical Center Groningen | |
| Metabolic Myopathy in Endocrinopathy | NCT05456997 | Cushing Syndrom... Pheochromocytom... Conns Syndrome Metabolic Myopa... | Muscle biopsy | 18 Years - | Barts & The London NHS Trust | |
| Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease | NCT00970970 | Von Hippel-Lind... Hemangioblastom... Renal Cell Carc... Pheochromocytom... Pancreatic Neur... | 89Zr bevacizuma... | 18 Years - | University Medical Center Groningen | |
| Genetic Factors and Pheochromocytomas in Neoplasia Type 2 | NCT05158712 | Neoplasia Pheochromocytom... | 18 Years - | Assistance Publique Hopitaux De Marseille | ||
| A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL | NCT05885386 | Pheochromocytom... Paraganglioma | Temozolomide | 10 Years - 70 Years | Peking Union Medical College Hospital | |
| Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions | NCT04071561 | Adrenal Tumor Adrenal Mass Pheochromocytom... Conn Adenoma Adrenal Metasta... Adrenal Hyperpl... | Posterior retro... Lateral transpe... | 18 Years - | University of Basel | |
| Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma | NCT01022515 | Pheochromocytom... Paraganglioma Essential Hyper... | plasma EM66 & C... usual follow up... | 18 Years - 90 Years | University Hospital, Rouen | |
| Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | NCT02961491 | Pheochromocytom... Paraganglioma | Ultratrace Iobe... | 12 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma | NCT03015844 | Neuroblastoma Pheochromocytom... | 131-I-meta-iodo... | 365 Days - 29 Years | Northwell Health | |
| 131MIBG to Treat Malignant Pheochromocytoma | NCT00028106 | Pheochromocytom... | [131]I-MIBG 6-[18F]Fluorodo... [123]I-MIBG | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma | NCT03015844 | Neuroblastoma Pheochromocytom... | 131-I-meta-iodo... | 365 Days - 29 Years | Northwell Health | |
| Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy | NCT06050057 | Adrenal Tumor Adrenal Disease Adrenal Mass Adrenalectomy; ... Adrenal Hyperpl... Adrenal Gland M... Adrenal Cortex ... Pheochromocytom... Cushing Syndrom... Conn Adenoma Adrenocortical ... Adrenocortical ... Adrenocortical ... | 18 Years - | University Hospital Olomouc | ||
| Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions | NCT04071561 | Adrenal Tumor Adrenal Mass Pheochromocytom... Conn Adenoma Adrenal Metasta... Adrenal Hyperpl... | Posterior retro... Lateral transpe... | 18 Years - | University of Basel | |
| Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study | NCT02618694 | Adrenal Mass Adrenal Disease Pheochromocytom... Cushing Syndrom... | Posterior retro... Transperitoneal... | - | Suez Canal University | |
| MIBG for Refractory Neuroblastoma and Pheochromocytoma | NCT01850888 | Relapsed Neurob... Metastatic Pheo... | 131 I-Metaiodob... Potassium iodid... G-CSF hematopoietic s... | 1 Year - | Masonic Cancer Center, University of Minnesota | |
| Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma | NCT00911729 | Pheochromocytom... Paraganglioma | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | ||
| Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma | NCT00107289 | Neuroblastoma Pheochromocytom... | iobenguane I 13... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Evaluation of Molecular Markers in Adrenal Tumors | NCT01348698 | Adrenal Gland N... | Tumor tissue bi... Surgery | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| RAD001 and Erlotinib in Patients With Neuroendocrine Tumors | NCT00843531 | Neuroendocrine ... | RAD001 erlotinib | 18 Years - | University of California, San Francisco | |
| RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid | NCT01152827 | Pheochromocytom... Extra-adrenal P... Non-functioning... | RAD001 | 18 Years - | Seoul National University Hospital | |
| Adrenal Tumors - Pathogenesis and Therapy | NCT00669266 | Adrenal Tumors Adrenocortical ... Cushing Syndrom... Conn Syndrome Pheochromocytom... | - 100 Years | University of Wuerzburg | ||
| Cryoablation of Bone Metastases From Endocrine Tumors | NCT03986593 | Neoplasm Metast... Thyroid Neoplas... Pheochromocytom... Adrenal Neoplas... Neuroendocrine ... Bone Metastases | cryoablation | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| Diagnosis and Treatment of Pheochromocytoma | NCT00001229 | Pheochromocytom... | - | National Institutes of Health Clinical Center (CC) | ||
| Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data | NCT06229405 | Adrenal Tumor Primary Aldoste... Cushing Syndrom... Pheochromocytom... Adrenal Cortica... | 19 Years - | Seoul National University Hospital | ||
| Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | NCT04891081 | Acyanotic Conge... Cyanotic Congen... Pheochromocytom... Paraganglioma | 18 Years - | University Medical Centre Ljubljana | ||
| Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders | NCT00001238 | Kidney Cancer Urologic Malign... Renal Cell Carc... Familial Renal ... Clear Cell Rena... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | NCT00466856 | Head and Neck C... Islet Cell Tumo... Metastatic Canc... Pheochromocytom... | octreotide acet... yttrium Y 90 re... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) | NCT04605848 | Pheochromocytom... Paraganglioma | Infrared themro... | 18 Years - 75 Years | University of Avignon | |
| Diagnosis and Treatment of Pheochromocytoma | NCT00001229 | Pheochromocytom... | - | National Institutes of Health Clinical Center (CC) | ||
| Magnesium and Dexmedetomidine in Pheochromocytoma | NCT05102058 | Phaeochromocyto... Hemodynamic Ins... | Magnesium-Dexme... | 18 Years - 75 Years | Istanbul University | |
| ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid | NCT00339131 | Pheochromocytom... Paraganglioma Carcinoid | Ultratrace iobe... | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma | NCT05636540 | Pheochromocytom... Paraganglioma | [18F]FluorThana... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma | NCT04320589 | Pheochromocytom... | Dexmedetomidine General anesthe... | 12 Years - 69 Years | National Cancer Institute, Egypt | |
| Blood Sampling for Neurochemical and Genetic Testing | NCT00001147 | Autonomic Nervo... Healthy Hypertension Pheochromocytom... | - | National Institutes of Health Clinical Center (CC) | ||
| DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies | NCT04895748 | Carcinoma, Rena... | DFF332 RAD001 PDR001 NIR178 | 12 Years - | Novartis | |
| 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma | NCT03541720 | Neuroblastoma Pheochromocytom... | 18F-DA | 1 Year - | St. Jude Children's Research Hospital | |
| 18F-FDOPA PET in Neuroendocrine Tumours | NCT02431715 | Thyroid Cancer,... Carcinoid Tumor Pheochromocytom... Paraganglioma Insulinoma Neuroblastoma | [18 F]-6-L-fluo... | 1 Month - | British Columbia Cancer Agency | |
| In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma | NCT05636540 | Pheochromocytom... Paraganglioma | [18F]FluorThana... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Diagnosis of Pheochromocytoma | NCT00004847 | Pheochromocytom... Endocrine Disea... Endocrine Disea... | ([18F]-DOPA) ([18F]-6F-DA) | 3 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma | NCT00458952 | Pheochromocytom... Paraganglioma | Ultratrace Iobe... | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma | NCT01967576 | Pheochromocytom... Paraganglioma | Axitinib (AG-01... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Pheochromocytoma and Hemodynamic Instability | NCT04566406 | Pheochromocytom... Hypertension Surgery | Laparoscopic ad... | 18 Years - | Jagiellonian University | |
| LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) | NCT03946527 | Paraganglioma Pheochromocytom... | Lanreotide | 18 Years - | Columbia University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
